Skip to main content

Table 4 VZV-related treatment

From: Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands

 

Varicella

Herpes zoster

Medication

Prescriptions

Varicella cases

Corrected

Prescriptions

HZ cases

Corrected

 

n

n

(%)

(%)

n

n

(%)

(%)

Anaesthetics

925

831

(15.8%)

13.5% *

518

364

(10.8%)

6.4%*

Analgesics

124

110

(2.1%)

−1.5%

1.097

577

(17.1%)

13.5%*

Antivirals (local)

17

17

(0.3%)

−1.2%

67

58

(1.7%)

0.1%

Antivirals (systemic)

24

21

(0.4%)

0.3%*

864

748

(22.2%)

22.0%*

Antibacterials (local)

588

487

(9.2%)

6.7%*

594

453

(13.4%)

10.9%*

Antibacterials (systemic)

678

568

(10.8%)

4.4%*

449

354

(10.5%)

4.5%*

Corticosteroids

394

316

(6.0%)

0.3%

372

316

(9.3%)

0.9%

Antipruritics and emollientia

1.136

1.004

(19.0%)

11.3%*

761

646

(19.2%)

11.5%*

Immunoglobulins

3

3

(0.1%)

0.1%

1

1

(0.03%)

0.03%

Vaccines

0

0

(0.0%)

0.0%

0

0

(0.00%)

0.0%

Total (any medication)

3.889

2.516

(47.7%)

 

4.723

2.286

(67.8%)

 
  1. * = p < 0.05.